Drug intelligence / Profile preview

panax notoginseng

Development stage
Phase 2
Lead developer
Xi'an Hospital of Traditional Chinese Medicine
Administration
Oral
01

Overview

Panax notoginseng, commonly known as Sanqi or Tienchi ginseng, is a perennial herb in the Araliaceae family native to East Asia. It is a cornerstone of traditional Chinese medicine, primarily utilized for its hemostatic, anti-thrombotic, and anti-inflammatory properties. The therapeutic effects are largely attributed to its high concentration of dammarane-type triterpene saponins, known as notoginsenosides. In modern clinical research, Panax notoginseng is being investigated for its potential to mitigate aspirin resistance and anti-platelet drug resistance in patients at risk for secondary stroke or cerebral infarction. Its mechanism of action involves the modulation of the TLR4/MyD88/NF-κB inflammatory signaling pathway and the inhibition of platelet activation and aggregation. Additionally, it is being explored in combination regimens for the treatment of colorectal cancer and the neuroprotection of patients in the recovery phase of ischemic stroke.

Brand names
Luotai
Other names
SanqiTienchi ginsengNotoginsengPanax pseudoginseng var. notoginseng
02

Targets

MYD88 (Myeloid differentiation primary response protein MyD88)NF-κBTLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on panax notoginseng.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on panax notoginseng.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call